Peripheral Artery Disease
Peripheral Artery Disease (PAD) is a vascular disorder characterized by the narrowing of arteries, most commonly in the legs and feet, due to atherosclerosis, resulting in reduced blood flow to these areas. This condition affects arteries that carry blood away from the heart to other body parts, excluding those that supply the heart or brain.
Health Outcomes
- Changed Walking Cadence
- Delayed Cardiac Pathology
- Enhanced Folate Synthesis
- Enhanced Wound Healing
- Improved 6-Meter Walk Performance
- Improved 6-minute Walking Distance
- Improved Aerobic Capacity
- Improved Aerobic Endurance Performance
- Improved Auto-Aggregation Capability
- Improved Cardiovascular Disease Marker
- Improved Cardiovascular Disease Outcomes
- Improved Cardiovascular Function
- Improved Cardiovascular Health
- Improved Cutaneous Blood Flow
- Improved Diabetic Foot Ulcer Healing
- Improved Distance Traveled
- Improved Endothelial Reactivity
- Improved Endothelium-Dependent Vasodilation
- Improved Endothelium-Independent Microvascular Vasodilation
- Improved Exercise Function
- Improved Fibrinolytic Activity
- Improved Flow-Mediated Dilation
- Improved Flow-Mediated Vasodilation
- Improved Intermittent Exercise Performance
- Improved Lactate Threshold
- Improved Limited Distance Test Performance
- Improved Lower Limb Peak Power
- Improved Maximal Exercise Capacity
- Improved Maximal Walking Performance
- Improved Mean Arterial Pressure
- Improved Microvascular Vasodilation
- Improved Pain-Free Walking Distance
- Improved Reactive Hyperemia Index
- Improved Run Time
- Improved Stress-Strain Index
- Improved Vascular Function
- Improved Vascular Function in Offspring
- Improved Vasodilation
- Improved Walking Ability
- Improved Walking Distance
- Improved Walking Speed
- Increased Angiogenesis
- Increased Endothelial Nitric Oxide Synthase Activity
- Increased Exercise Capacity
- Increased Nitric Oxide Bioavailability
- Increased Plasma Nitric Oxide Levels
- Increased Shear Force
- Increased Walking Speed
- No Change in Major Cardiovascular Event
- Reduced Anaerobic Lactic Energy
- Reduced Angiogenesis
- Reduced Aortic Superoxide Levels
- Reduced Apolipoprotein B-100 to Apolipoprotein A-1 Ratio
- Reduced Arterial Stiffness
- Reduced Atherogenic Index
- Reduced Atherosclerosis Risk Factors
- Reduced Atherosclerotic Cardiovascular Disease Event
- Reduced Atherosclerotic Plaque Formation
- Reduced Cadence
- Reduced Cardiovascular Dysfunction
- Reduced Cardiovascular Event
- Reduced Cardiovascular Mortality
- Reduced Central Blood Pressure
- Reduced Cerebrovascular Mortality
- Reduced Contrast-Induced Acute Kidney Injury
- Reduced Debridement Time
- Reduced HMG-CoA Reductase Inhibition
- Reduced Incidence of Footpad Lesions
- Reduced Intimal Thickening
- Reduced Leg Adiposity
- Reduced Monocyte Adhesion
- Reduced Plaque
- Reduced Skin Sensitivity
- Reduced TMAO Level
- Reduced Thrombosis
- Reduced Ulcer Size
- Reduced Vascular Damage
- Reduced Vascular Restenosis
- Reduced Walking Time
- Reduced Wound Area